Urgent.News

What's breaking now, across thousands of outlets.

Business

Mir Raza death: SHC forms judicial commission despite family’s opposition

The Sindh High Court (SHC) on Monday constituted a judicial commission to investigate the killing of young Karachi businessman Mir Raza, Aaj News reported. SHC Justice Umar Sial has been appointed head of the judicial commission, with the chief justice of the Sindh High Court issuing a notification regarding his nomination. The SHC Directorate has also informed the Sindh Home Department about the…

Mir Raza death: SHC forms judicial commission despite family’s opposition

Sindh High Court has created a judicial commission to probe the murder of Karachi businessman Mir Raza, despite his family's objections. Justice Umar Sial leads the commission, with the Chief Justice of Sindh High Court confirming his appointment via a notification. The SHC Directorate has also alerted the Sindh Home Department about this action.

Mir Raza's family had previously sought the establishment of a joint investigation team (JIT) instead of a judicial commission, but their request was denied. The family's lawyer, Jibran Nasir, expressed concerns over the police's progress and evidence handling, questioning the preservation of CCTV footage and the alleged negligence of officials.

He also highlighted that the government had not formally informed the family about the nomination of a high court judge for the judicial commission. Jibran suggested an empowered JIT with representatives from various security and intelligence agencies instead. The court extended Mir Raza's business partner, Muhammad Ahmed's, interim bail until September 1.

Ahmed's attorney argued that business partners often face false accusations, and his client had been summoned multiple times to the police station. However, the family's lawyer denied this claim, stating that Ahmed was not facing imminent arrest and that his presence was crucial for the investigation.

Written by urgent.news from Business Recorder's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at brecorder.com →

More in Business

K-Bio Exports Top $11 Billion Amid Deal Surge

Expectations are growing that domestic pharmaceutical and bio companies will break last year’s all-time record performance as they successively succeed in technology exports in the second half of the…

  • K-Bio exports surpassed $11 billion in 2022, according to industry statement.
  • Hanmi Pharmaceutical secured $2.3 billion license deal for obesity treatment HM17321.
  • Multiple Korean companies signed license agreements for novel technologies in second half of 2023.

More from Monday 24 August →